Ana Oaknin

35.6k total citations · 15 hit papers
320 papers, 12.7k citations indexed

About

Ana Oaknin is a scholar working on Oncology, Reproductive Medicine and Obstetrics and Gynecology. According to data from OpenAlex, Ana Oaknin has authored 320 papers receiving a total of 12.7k indexed citations (citations by other indexed papers that have themselves been cited), including 198 papers in Oncology, 171 papers in Reproductive Medicine and 87 papers in Obstetrics and Gynecology. Recurrent topics in Ana Oaknin's work include Ovarian cancer diagnosis and treatment (168 papers), Endometrial and Cervical Cancer Treatments (87 papers) and PARP inhibition in cancer therapy (86 papers). Ana Oaknin is often cited by papers focused on Ovarian cancer diagnosis and treatment (168 papers), Endometrial and Cervical Cancer Treatments (87 papers) and PARP inhibition in cancer therapy (86 papers). Ana Oaknin collaborates with scholars based in Spain, United States and Italy. Ana Oaknin's co-authors include Paul A. Cohen, Lynette Denny, A. Jhingran, Richard T. Penson, Isabelle Ray‐Coquard, Bradley J. Monk, Andrew Tutt, Ursula A. Matulonis, Domenica Lorusso and Vicky Makker and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Nature Communications.

In The Last Decade

Ana Oaknin

308 papers receiving 12.5k citations

Hit Papers

Oral poly(ADP-ribose) polymerase inhibitor olaparib in pa... 2010 2026 2015 2020 2010 2019 2014 2014 2019 500 1000 1.5k

Peers

Ana Oaknin
Comparison fields: 5 of 139
  • Oncology 6.8k
  • Reproductive Medicine 4.4k
  • Molecular Biology 3.8k
  • Obstetrics and Gynecology 3.2k
  • Surgery 1.8k
Replace Sandro Pignata with:
Sandro Pignata Italy
Vincent T.H.B.M. Smit Netherlands
Jonathan A. Ledermann United Kingdom
Carol Aghajanian United States
John K. Chan United States
Gunnar B. Kristensen Norway
Robert A. Burger United States
Nicoletta Colombo Italy
Harry Hollema Netherlands
Krishnansu S. Tewari United States
Sandro Pignata Italy View profile →
Citations per field, relative to Ana Oaknin
Ana Oaknin · 1×
Citations per year, relative to Ana Oaknin
Ana Oaknin · 1×

Countries citing papers authored by Ana Oaknin

Since Specialization
Citations

This map shows the geographic impact of Ana Oaknin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Oaknin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Oaknin more than expected).

Fields of papers citing papers by Ana Oaknin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Oaknin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Oaknin. The network helps show where Ana Oaknin may publish in the future.

Co-authorship network of co-authors of Ana Oaknin

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Oaknin. A scholar is included among the top collaborators of Ana Oaknin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Oaknin. Ana Oaknin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 1
2 5
3 18
4 2
5 4
6 5
7 2
8 6
9 3
10 18
11 16
12 1
13 0
14 1
15 5
16 1
17 36
18 95
19
Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer breakdown →
359
20
Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial breakdown →
1117

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026